Exhaled volatile organic compounds as markers for medication use in asthma.
Paul BrinkmanWaqar M AhmedCristina GómezHugo H KnobelHans WedaTeunis J VinkTamara M NijsenCraig E WheelockSven-Erik DahlenPaolo MontuschiRichard G KnowlesSusanne J VijverbergAnke H Maitland-van der ZeePeter J SterkStephen J Fowlernull nullPublished in: The European respiratory journal (2020)
We have linked exhaled VOCs to urinary detection of salbutamol and OCSs. This merits further development of breathomics into a point-of-care tool for therapeutic drug monitoring.